NT-pro-BNP水平与原发性阿尔多斯特罗尼斯症患者的左心室重塑有关
Tao Wu1, Chenxiao Xu2, Lu Tang1
1Department of Radiology, West China Hospital, Sichuan University.
概括
N-终端亲B型尿素 (NT-pro-BNP) 水平与原发性阿尔多斯特症 (PA) 患者的左心室重塑相关. 这突出了NT-pro-BNP的重点.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 医疗成像医学成像
背景情况:
- 原发性阿尔多斯子症 (PA) 与心血管并发症有关.
- 左心室 (LV) 改造是心脏损伤的关键指标.
- 心脏磁共振 (CMR) 提供了对LV重塑的详细评估.
研究的目的:
- 为了研究NT-pro-BNP水平和通过PA患者的CMR获得的LV重塑参数之间的关联.
- 为了比较PA和基本高血压 (EH) 患者之间的LV重塑和NT-pro-BNP水平.
主要方法:
- 前性研究包括74名PA和39名EH患者.
- 进行心脏磁共振成像 (CMR) 来评估LV功能,T1映射和应变参数.
- 在CMR之前测量了血NT-pro-BNP水平.
- 统计分析包括t测试,奇平方测试,斯皮尔曼相关性和线性回归.
主要成果:
- 与EH患者相比,PA患者的NT-pro-BNP和原生T1水平显著更高.
- 异常的NT-pro-BNP水平与明显的LV重塑参数有关.
- NT-pro-BNP水平与原生T1,细胞外体积和各种菌株参数 (全球周边,纵向和辐射) 独立相关.
结论:
- NT-pro-BNP水平与PA患者的CMR确定的左心室重塑参数有显著的关系.
- 在PA患者的常规NT-pro-BNP评估可以提供有关心脏状况的宝贵见解.
- 这种关联强调了监测NT-pro-BNP对于PA中心血管风险分层的重要性.
更多相关视频
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.4K
07:31A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
10.0K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
404
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
01:17Antihypertensive Drugs: Action of β1 Blockers
327
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
327
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
68
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
68
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Heart Failure Drugs: β-Blockers
322
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
322